Cepheid receives FDA clearance for Xpert Hemorrhagic Fever Panel test

The U.S. FDA has cleared Cepheid's Xpert Hemorrhagic Fever Panel, a multiplex PCR test that simultaneously detects RNA from Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever viruses from a single sample in approximately 61 minutes on GeneXpert Dx systems.

Why it matters. The test enables rapid, simultaneous detection of multiple high-consequence viral hemorrhagic fevers, supporting timely patient isolation, infection prevention, and public health notification, particularly in regions where early symptoms…